Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype - Test2 - elhamkhani - TriplyDB

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

http://www.wikidata.org/entity/Q26252060

about

Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species Zika virus: from pathogenesis to disease control Zika Virus Antagonizes Type I Interferon Responses during Infection of Human Dendritic Cells Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Zika Virus Pathogenesis and Tissue Tropism A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis Antibody responses to Zika virus infections in flavivirus-endemic environments Protective efficacy of Zika vaccine in AG129 mouse model Vaccination strategies against Zika virus Tissue tropisms, infection kinetics, histologic lesions, and antibody response of the MR766 strain of Zika virus in a murine model High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus Transposon mutagenesis of the Zika virus genome highlights regions essential for RNA replication and restricted for immune evasion.Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Prospects for a Zika Virus Vaccine.Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells.Rapid development of a DNA vaccine for Zika virus Pushing Forward With Zika Vaccines Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus.Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.Taking the Defensive: Immune Control of Zika Virus Infection.Zika Virus: Immunity and Vaccine Development.Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?Modified mRNA Vaccines Protect against Zika Virus Infection.Zika virus infection confers protection against West Nile virus challenge in mice.Innate, T and B Cell Responses in Acute Human Zika Patients.Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine.A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model.After the epidemic: Zika virus projections for Latin America and the Caribbean.Zika virus: what we need to know?Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection.Zika Virus Vaccine Development.Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo.Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection.Development of Zika Virus Vaccines.

P2860

Q26970782-A79D4E99-EA57-4BC3-85E4-E2F7E13869AB Q27980556-5A2D1469-2614-4D7B-9512-E8CBD8073384 Q28119651-23C63A9B-A0EE-44A9-A62F-CE4C3D4F959B Q28278045-CB93DB43-C07B-4569-AFA1-335DFAEA155F Q28656345-2748D977-899A-4ADE-9B31-66E82DCB51B5 Q28656365-D9FFCB00-3FA4-4488-84DB-83BD17D728AE Q28733400-44033B72-4F11-4166-959D-F6BA9F948F8E Q28804076-B6B6EB43-17CE-440D-B500-D88402A248A0 Q28804225-1845D07C-C7FA-47DA-AFAC-A46097BB9582 Q28827957-B4AB4698-DEBD-4650-AB26-D187EFF589E5 Q29378065-A87B0F05-36A5-4610-A5BA-30E951E66305 Q29571224-264B27FA-0EA0-4DE1-8487-E5429B481EB1 Q29572516-25AE3B6D-8245-4DEE-8EDA-0573C0275E68 Q30145554-26B96F85-EFC7-47CD-B39C-F42A84E87E62 Q30145598-8B56D5C2-CFFB-4A17-AD21-B224A16659BE Q30145641-7AE22E0E-ACFA-447B-9E65-F19187C24B67 Q30235612-0A97599D-FAFA-4A4A-A962-A8E34FA71753 Q30402859-CCD9710C-2E51-4124-9C5E-CC77077F2155 Q33681310-FE7F57F0-540F-4CAD-A477-512BAC934FFD Q34542032-ACA91C08-FCF7-41B0-AE9C-E330FA35C8E8 Q37604641-CDBF69BE-63A3-4531-BE20-5C4E503E7833 Q38156855-4242AFA3-3724-4CB7-B874-763657D40BAF Q38157833-83F082C8-DF4C-41BD-84D4-F80DC571B8F0 Q38848948-B7595A55-A044-47C8-8862-36E78352B626 Q38969772-B78512DB-4CED-4239-AE05-9A35E96DA76D Q40037723-976ADD86-B6F8-4625-B16D-35ABA517BF68 Q40049416-A77A3B91-86F6-4B8D-9026-25C7C4EF3C12 Q41918368-3C8AC014-43AA-4BD1-AE1A-8F1D7623F44B Q41919129-AC3D618D-FFD7-427A-AE17-C7BACF2EB5B4 Q41929032-39A407A0-085F-404D-B755-50F9F836CF25 Q42347745-F984A6D7-2C0D-4F3E-9891-D343E8793FC8 Q43046676-D835F6EA-83E3-4BA2-B22D-67FB9E58B4A0 Q43046951-3CBCCB5F-F36B-44D9-8CEC-88D82A51AC16 Q44169814-DEF2A4EC-0039-42F4-9A87-F137A1DB5731 Q45324741-A1A4B013-5F4A-411F-9329-435A9BB19818 Q47006432-3327B3D9-C99F-4CFF-A13C-A1CF6159B110 Q47202176-D0D39D68-1DC5-49F8-A604-E8DD2CABF3C8 Q47244845-E935AF04-2C85-468D-A870-FC487BEFCDA9 Q47269331-42B026C5-F7FA-4A32-9B28-5C8C325D9FCD Q47551875-AE6FFA7C-28E9-4C76-8D12-C941986B0D3B

P2860

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

http://www.wikidata.org/entity/Q26252060

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@ast

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@en

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@nl

type

label

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@ast

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@en

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@nl

prefLabel

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@ast

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@en

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@nl

P1433

Q26252060-C02A4148-41A9-4F70-AE49-F0CBBC4EF251

P1476

Q26252060-2F97926B-C51C-468C-A5EB-EC6408FDCFEC

P2093

Q26252060-119F3F1A-D280-439A-90B1-E37D6E574EEF

Q26252060-1B116F0C-9595-48C4-A0CC-7F137F220961

Q26252060-311F9E30-11E2-4098-B178-16CF1C7E933B

Q26252060-662892DA-4C72-4DFC-B574-FB6E05E99F68

Q26252060-94CC4F32-0794-440F-A862-49F3CF68AAAB

Q26252060-9C580E94-3C3A-44D3-8D13-68933BF4DF53

P248

Q26252060-518DDB5F-C977-4DE4-B867-647E7994F529

P2860

Q26252060-01159755-CD33-4852-8C29-7BCC72CC3C4A

Q26252060-04054BFE-6A97-4C87-BF63-95C9D26B2C62

Q26252060-101211EA-C1CD-4266-BB2C-2802CF932E86

Q26252060-1216DE48-FDE5-4BFA-9706-36DF430C0CBD

Q26252060-13BB2C65-B200-48FC-81BC-F9FC3D0D4ACB

Q26252060-151CDBA2-C566-4FF9-A868-F7281061C5E1

Q26252060-17529EFC-BE29-402D-9118-57F3D75AD1D2

Q26252060-2083702E-D865-4334-97B6-EBD7EF0CCDD4

Q26252060-262C470D-A09E-4C8E-8602-DC10103EEB65

Q26252060-267C5A05-7136-4CB2-A21C-FD416F36BFED

P304

Q26252060-64FE3E3E-D788-4E6E-BE63-C09D38584E7B

P31

Q26252060-89F9EE1D-B5BB-4C72-B43D-04E7A852519C

P3181

Q26252060-37E0994A-E36D-4FAB-B85C-B8B0270ECB7E

P356

Q26252060-CD63A3B5-20DF-40E6-B156-171F73D9326A

P407

Q26252060-DE040B1D-7396-420B-AA9C-937D235A7723

P433

Q26252060-9E6CD200-84ED-417E-AE73-1E21A237DECA

P478

Q26252060-A0D6E6D4-3C3D-4A04-A98A-578DEC1CC4B9

P50

Q26252060-093FB0B7-D4E2-4BF7-9A0B-BB20F657EFD2

Q26252060-0FBEB656-D24E-4435-84E5-78864579A1C4

Q26252060-160E9229-E8A2-4B3A-8E59-A4BC2D3FA854

Q26252060-49B00EB0-451C-4341-9BF1-42FE3540DDCE

Q26252060-593C3EAE-6BCB-456E-99CB-1542DED660F1

Q26252060-6CA75378-4238-4C8C-9089-744E368B4D15

Q26252060-E517243D-F0ED-4307-9D9A-CAE70BDE7C65

P5008

Q26252060-26BF0C89-EA62-46D5-BDE1-23A137DAA406

P577

Q26252060-EB4D0B09-9109-4EE0-81F2-6DD4CFC3DA72

P698

Q26252060-620FBEA1-9486-47E5-8880-2950A387F972

P921

Q26252060-D8B920F2-2EED-4C92-9ECE-EE5A2A70B6C7

P932

Q26252060-754FBD6C-D7F5-40DE-970F-658CEDEE022F

P3181

P356

J.CELREP.2016.07.049

P1433

P1476

Broadly Neutralizing Activity ...... tifies a Single Viral Serotype

@en

P2093

Alexander R.Y. Smith

http://www.w3.org/2001/XMLSchema#string

Christina R. DeMaso

http://www.w3.org/2001/XMLSchema#string

Derek J. Platt

http://www.w3.org/2001/XMLSchema#string

Mark J. Mulligan

http://www.w3.org/2001/XMLSchema#string

Scott D. Speer

http://www.w3.org/2001/XMLSchema#string

Theodore C. Pierson

http://www.w3.org/2001/XMLSchema#string

P248

OpenCitations Corpus

P2860

Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage

Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013

Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013

Epidemiological notes on some viruses isolated in Uganda; Yellow fever, Rift Valley fever, Bwamba fever, West Nile, Mengo, Semliki forest, Bunyamwera, Ntaya, Uganda S and Zika viruses

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

Mechanism and significance of cell type-dependent neutralization of flaviviruses

Characterization of a Novel Murine Model to Study Zika Virus

The 3.8 Å resolution cryo-EM structure of Zika virus

Computed Tomographic Findings in Microcephaly Associated with Zika Virus

P304

1485-1491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3659945

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELREP.2016.07.049

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Julie Ledgerwood

Michael S. Diamond

Kimberly A Dowd

Barney S. Graham

P5008

WikiProject Zika Corpus

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27481466

http://www.w3.org/2001/XMLSchema#string

P921

P932

5004740

http://www.w3.org/2001/XMLSchema#string